Delivery Order SPE2DB20D9214-SPE2DB24FD4WT

Award Date 9/12/24
Potential Completion Date 9/13/24
Potential Value $29K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,443.50 firm fixed-price delivery order is for the supply of FASENRA 30 MG/ML SYRINGEML and has a completion date of July 17, 2024. This award is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,330.50 contract is for the supply of the specialty pharmaceutical product FASENRA 30 MG/ML SYRINGE. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,330.50 firm-fixed-price delivery order is for the provision of FASENRA 30 MG/ML SYRINGEML, a pharmaceutical product. The contract has an ultimate completion date of July 1, 2024 and was awarded on June 28, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) with DMS...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,330.50 firm fixed-price delivery order is for the supply of FASENRA 30 MG/ML SYRINGEML, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,330.50 firm fixed-price delivery order is for the supply of FASENRA 30 MG/ML SYRINGEML, a pharmaceutical product, with a contract completion date of June 24, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the delivery of FASENRA 30 MG/ML syringes. The $2,443.50 contract is a delivery order issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA for pharmaceutical supplies supporting military medical facilities globally. This IDC, which runs through December 31,...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,887.00, is for the delivery of FASENRA PEN 30 MG/MLML. The award is a delivery order under an existing indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA, valued at up to $499,999,999. This single-award IDC, under the SPE2DB program, allows...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $31,765.50, is for the delivery of a specific pharmaceutical product, FASENRA 30 MG/ML SYRINGEML, and has a completion date of June 6, 2024. This award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,330.50 firm fixed-price delivery order is for the supply of FASENRA 30 MG/ML SYRINGE medical products, with a completion date of June 12, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,330.50 contract covers the delivery of FASENRA 30 MG/ML SYRINGEML, a specialized pharmaceutical product, to support the medical supply needs of the Department of Defense (DoD). The contract is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage...
  • SPE2DB20D9214
    Indefinite Delivery Contract
  • SPE2DB20D9214-SPE2DB24FD4WT
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $29,322.00 firm fixed-price delivery order contract is for the provision of FASENRA 30 MG/ML syringes and does not have a set-aside designation.

The award is associated with a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. Through this vehicle, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical requirements of the Department of Defense healthcare system.

Generated 12/12/24, 9:32 AM